Disseminated intravascular coagulation is a coagulopathy characterized by thrombocytopenia, elevated D-dimer levels, prolonged prothrombin time, and reduced fibrinogen; it has been associated with a poor prognosis in COVID-19 patients (34, 35). The gene discussed is F2; the disease is blood coagulation disease.